Commonly reported side effects (incidence 5%) include: nausea, diarrhea, constipation, vomiting, injection site reactions, headache, low blood sugar, heartburn, fatigue (sleepiness), dizziness, stomach-area pain, increased lipase (a pancreatic enzyme), upper stomach-area pain, fever, and stomach infection (gastroenteritis)
Qsymia has no direct glucose-lowering mechanism
What was the specific finding of the 2017 Cell study that established FOXO4-DRI
Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1
Compounded medications: * Are NOT FDA-approved * Have not undergone FDA review for safety or effectiveness * May differ in strength, quality, and purity from FDA-approved products * Are prescribed when commercially available options may not meet individual patient needs
The loading phase requires 4mg to 5mg weekly for the first month, which represents a meaningful investment